四环医药:跨越制药边界 成就美与创新

华福证券
10 Jun

以制药企业的严谨与创新,打造中国领先医美及生物制药企业。四环医药坚持“医美+创新药”的双轮驱动战略,成功实现转型升级。旗下拥有渼颜实验室、轩竹生物、惠升生物、澳合研究院等四大自主研发平台,聚焦医美、肿瘤、代谢、糖尿病、心脑血管等治疗领域。2021 年独家代理的韩国肉毒毒素产品乐提葆上市销售,标志医美版图的正式落地。成长至2024 年,公司整体收入规模已达19.0 亿元,毛利率水平约65.3%,在手...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10